Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ETCompany ParticipantsAJ Schwabe - Corporate ParticipantBruce C.

Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today announced preliminary financial results for the second quarter and first half ...

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

The horror-comedy, elegantly set in rural Karnataka, also features the versatile Raj B. Shetty in an intriguing role. The ...

Readers respond to a guest essay by Meghan O’Rourke about artificial intelligence. Also: Port and privacy; the G.O.P. vs. NPR ...

Productive FDA Meeting Highlights Path Toward Overdose Protection Labeling and 505(b)(2) Regulatory Strategy ~~ FDA and Ensysce Aligned on Collaborative Approach to Ensure Product's Full Safety ...

As B2B marketers work to modernize GTM strategies and scale impact, 2X's Lisa Cole has written an alternative to the ...

Golnaz Arastoopour Irgens, assistant professor of human-centered technologies at Vanderbilt University and a former middle ...

Q2 2025 Earnings Call Transcript July 21, 2025 Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2025 ...

Cash Position: GeoVax reported cash balances of $3,093,862 at June 30, 2025, as compared to $5,506,941 at December 31, 2024. During July 2025, the Company completed a public offering of common stock ...

Operator: Good morning, and welcome to the Dorian LPG First Quarter 2026 Earnings Conference Call. [Operator Instructions] As ...

Discover the healthiest wellness shots made with turmeric, ginger, and more, plus tips on how to make them at home and ...